Ashley Gallagher, MA

Novo Nordisk announced headline results from the REIMAGINE 2 (NCT06065540) phase 3 trial, revealing that its experimental therapy, CagriSema, achieved statistically significant superiority in both blood glucose control and weight …

The management of diabetes in specialized populations, particularly children and pregnant women, is entering a new era as inhaled Technosphere insulin (TI) emerges as a potential solution to long-standing therapeutic …

Diabetes remission is defined as maintaining a hemoglobin A1c (HbA1c) level of less than 6.5% for at least 3 months without the use of glucose-lowering medications. Although traditional type 2 …

Recent findings from a 12-week prospective study have illuminated the potential of high-dose vitamin D3 as a strategic tool for managing metabolic health in patients with type 2 diabetes (T2D). …